<DOC>
	<DOCNO>NCT00329186</DOCNO>
	<brief_summary>The purpose study determine relative difference PK extensive metabolizers ( EMs ) poor metabolizers ( PMs ) desvenlafaxine SR venlafaxine ER single dose administer .</brief_summary>
	<brief_title>Study Evaluating Pharmacokinetics Venlafaxine ER Desvenlafaxine SR Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Desvenlafaxine Succinate</mesh_term>
	<criteria>Healthy men woman 18 55 year age Healthy determine investigator basis medical history physical examination , laboratory test result , vital sign , clinically significant abnormality 12lead electrocardiogram ( ECG ) History nonsmoker least 1 year Presence history disorder significant cardiovascular , hepatic , renal , respiratory , gastrointestinal , endocrine , immunologic , dermatologic , hematologic , neurologic , severe condition ear , eye throat ( glaucoma increase intraocular pressure ) , psychiatric disease may prevent completion study Known suspect alcohol abuse consumption 2 standard unit per day within past 6 month know suspected abuse prohibit drug substance Use overthecounter , prescription , hormonal therapy investigational medication within 30 day study day 1 end study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Healthy Subjects</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Depression</keyword>
	<keyword>Cytochrome P-450 CYP2D6</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Health</keyword>
</DOC>